Mega Genomics (HKSE:06667) 3-Year ROIIC % : 146.98% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Mega Genomics 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Mega Genomics's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 146.98%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Mega Genomics's 3-Year ROIIC % or its related term are showing as below:

HKSE:06667's 3-Year ROIIC % is ranked better than
91.4% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.94 vs HKSE:06667: 146.98

Mega Genomics 3-Year ROIIC % Historical Data

The historical data trend for Mega Genomics's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Genomics 3-Year ROIIC % Chart

Mega Genomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

3-Year ROIIC %

-75.68

146.98

Mega Genomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
3-Year ROIIC %	Get a 7-Day Free Trial				-	-75.68	-	146.98	-

Competitive Comparison of Mega Genomics's 3-Year ROIIC %

For the Diagnostics & Research subindustry, Mega Genomics's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mega Genomics's 3-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Mega Genomics's 3-Year ROIIC % falls into.

Mega Genomics 3-Year ROIIC % Calculation

Mega Genomics's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %	=	3-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	3-Year Incremental Invested Capital^**
	=	( 16.8243689 (Dec. 2023) - 108.064942 (Dec. 2020) )	/	( 252.134 (Dec. 2023) - 314.21 (Dec. 2020) )
	=	-91.2405731	/	-62.076
	=	146.98%^***

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Mega Genomics (HKSE:06667) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Mega Genomics 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Mega Genomics's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mega Genomics Ltd (HKSE:06667) » Definitions » 3-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

North Garden Road, 401 Health Work, Haidian District, Beijing, CHN

Website

https://www.megagenomics.cn

Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening, and infectious disease diagnosis, to meet consumers growing preventive medical needs. It generates a majority of its revenue from consumer genetic testing services.

Executives

Yu Rong	2501 Other
Guo Meiling	2101 Beneficial owner
Lin Lin	2101 Beneficial owner
Infinite Galaxy Health Limited	2101 Beneficial owner
Mei Nian Investment Limited	2101 Beneficial owner
Kastle Limited	2501 Other
Mega Marvelous Limited	2501 Other
Yurong Technology Limited	2101 Beneficial owner
Niu Zhencai	2201 Interest of corporation controlled by you
Mei Nian Da Jian Kang Chan Ye Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing He He Heng Ye Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Shi Ji Yu Neng Ke Ji You Xian Gong Si	2501 Other
Tian Jin Shi Ji Yu Neng Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner

Mega Genomics Headlines

No Headlines